Navigation Links
CQRC Statement on the NY Times Article on Medicare's Home Oxygen Benefit
Date:11/30/2007

WASHINGTON, Nov. 30 /PRNewswire-USNewswire/ -- Today's New York Times story on home oxygen therapy omits salient facts about home oxygen therapy and the critical role it plays in keeping some of Medicare's sickest beneficiaries in their own homes as they manage the effects of debilitating and irreversible lung disease.

The story inappropriately treats home oxygen therapy as though it is nothing more than the rental of inert equipment, when in fact home oxygen is a prescribed therapy, that when properly administered, requires both medical devices and myriad patient services. Oxygen providers deliver critical services that help this oft-overlooked beneficiary segment manage their chronic disease and therapy between physician visits, which in turn helps to avoid costly hospital admissions, serious complications, and sometimes even death. Home oxygen providers are often the physician's eyes and ears in the patient's home setting.

Home Oxygen Therapy is an important and cost-effective treatment for COPD. Every year, millions of Medicare beneficiaries are treated for the effects of chronic obstructive pulmonary disease, or COPD. COPD is a progressive, non-curable disease that causes irreversible loss of lung function and threatens the ability of patients to perform even routine, daily tasks. COPD is the fourth largest killer in the United States. The average home oxygen patient is a 73-year old, frail female who lives alone, does not drive and takes multiple medications for multiple disease conditions. The sickest COPD patients need oxygen therapy to breathe and remain stable at home. Oxygen therapy providers are often the first line of care for these patients -- helping to maintain proper patient compliance with their prescribed oxygen therapy, thereby helping to slow lung degeneration and avoid hospitalizations.

These points were reinforced in a separate article reported in the Wednesday, November 28th New York Times story by Denise Gra
'/>"/>

SOURCE CQRC
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. Olympic Gold Medalist Marion Jones-Thompson Pleads Guilty to Making False Statements in Two Separate Federal Criminal Investigations
2. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
3. Takeda statement on ACTOS meta-analysis published in the Journal of the American Medical Association
4. Takeda Statement on ACTOS(R) (Pioglitazone HCl) Meta-Analysis Published in the Journal of the American Medical Association
5. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
6. Statement by Oscar S. Wyatt, Jr.
7. Statement from Employment Policies Institute on Senator Hillary Clintons Health Care Plan
8. Pelosi Statement on Proposed Entitlement Task Force
9. Statement by Robert Greenstein, Executive Director of the Center on Budget and Policy Priorities, on the New Congressional SCHIP Agreement
10. Statement on House/Senate Agreement on SCHIP Legislation
11. Statement from the Alliance for Quality Nursing Home Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2012)... Kathleen Doheny HealthDay Reporter , , TUESDAY, May ... type 2 diabetes with earlier development of precancerous colon ... colorectal screenings at a younger age than others. ... diabetes should get screenings earlier, possibly at age 40, ... a clinical gastroenterology fellow at Washington University in St. ...
(Date:5/22/2012)... Healthier lifestyles and better disease management led to a ... between 1997 and 2006, especially deaths caused by ... shows. During that time, deaths from all causes ... deaths caused by heart disease and stroke in this ... of 1997-2004 National Health Interview Survey data on nearly ...
(Date:5/22/2012)... Pushed to the brink of survival, the hyper-driven ... system that has helped organisms cope with internal stresses ... integral part of this system, heat shock protein 90 ... the genetic changes and profound disturbances in normal biology ... that inhibiting HSP90 just might render breast cancer cells ...
(Date:5/22/2012)... quite common for a female song sparrow to stray ... next door, but a new study shows that sleeping ... is reported in The American Naturalist, found ... to have lower reproductive success than within-pair offspring. The ... ostensibly monogamous animals might be inclined to cheat. , ...
(Date:5/22/2012)... have developed a microfluidic chip to test for latent ... and more reliable than current testing for the disease. ... in real time," said Ying Liu, a research specialist ... Department of Biomedical Engineering. , The team has already ... and the United States. , About one-third of the ...
Breaking Medicine News(10 mins):Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 2Health News:Middle-Aged Diabetics May Need Earlier Colon Checks 3Health News:U.S. Sees Drop in Deaths Linked to Diabetes 2Health News:U.S. Sees Drop in Deaths Linked to Diabetes 3Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 2Health News:Breast cancer clinical trial tests combo of heat shock protein inhibitor and hormonal therapy 3Health News:For monogamous sparrows, it doesn't pay to stray (but they do it anyway) 2Health News:New TB test promises to be cheap and fast 2
... waiting, bracing and, sometimes, surgery, , , SUNDAY, May 11 (HealthDay ... that you can bend, twist, reach and more. , But, ... develop properly and the spine takes on an "S" or ... it affects about 6 million Americans, according to the National ...
... play smart to avoid devastating vision injuries, group ... Every year in the United States, about 40,000 ... Academy of Ophthalmology (AAO), which recommends that all ... by an eye-care professional. , Lenses made from ...
... for ADHD, INDIANAPOLIS, May 8 ... announced today that the United States Food ... HCI) for,maintenance treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) ... reuptake,inhibitor, is the first FDA-approved non-stimulant to ...
... Operation USA has,deployed staff already stationed in Asia to ... million people affected by the recent cyclone which,destroyed or ... near Yangon (formerly the capital Rangoon) and throughout its ... 120 miles per hour and,struck communities living largely in ...
... Iraq and Afghanistan Veterans Gather in Virginia to,Envision a ... CHANTILLY, Va., May 9 As the war in ... climbs above 4,000 and,casualty numbers approach the 30,000 mark, ... the homefront have organized to help,bereaved families and wounded ...
... demands reap mental benefits regardless of age or ... News) -- Having an intellectually demanding job that ... abilities during retirement, regardless of intelligence, education level ... suggests. , "Our society is expected to live ...
Other Medicine News:Health News:Scoliosis: An Unnatural Curve 2Health News:Scoliosis: An Unnatural Curve 3Health News:Protective Eyewear Key to Sports Safety 2Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 2Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 3Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 4Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 5Health News:FDA Approves Strattera(R) for Maintenance of ADHD in Children and Adolescents 6Health News:Los Angeles Based Operation USA Appeals for Funds to Aid in Myanmar (Burmese) Cyclone Disaster (Updated) 2Health News:Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008 2Health News:Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008 3Health News:Leading Veterans Service Organizations Meet Near Washington May 13-15, 2008 4Health News:Demanding Jobs May Pay Cognitive Dividends in Retirement 2
(Date:5/22/2012)... May 22, 2012 Sorbent Therapeutics, Inc. ... renal diseases, presented positive data from its Phase ... of 111 heart failure patients with chronic kidney ... as compared to placebo.    Data ... presented in an oral session at the Annual ...
(Date:5/22/2012)... ALBANY, N.Y., May 22, 2012   AMRI ... research and manufacturing organization, announced today the appointment of ... Thomas D,Ambra, Ph.D., chairman, president and CEO. In this ... AMRI,s business operations in Europe, including the company,s site ... European-based business development team. As the founder of Excelsyn, ...
(Date:5/22/2012)... Prosolia, Inc. and AB SCIEX announced today that they ... by Dr. Gary Van Berkel and his colleagues of ... an innovator in the field of mass spectrometry and ... in the field.  The agreement provides Prosolia a license ... methods based on the liquid micro- junction surface sampling ...
Breaking Medicine Technology:Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 2Sorbent Therapeutics' CLP1001 Improves Heart Failure Symptoms In Phase 2 Clinical Study 3AMRI Announces President for AMRI Europe 2AMRI Announces President for AMRI Europe 3Prosolia and AB SCIEX reach licensing agreement 2Express Scripts to Present at the J P Morgan Healthcare Conference 13562 1Accuray Elevated to NASDAQ Global Select Market 13561 1Accuray Elevated to NASDAQ Global Select Market 13561 2Accuray Elevated to NASDAQ Global Select Market 13561 3Veridex LLC Announces Collaboration to Develop Next Generation Circulating Tumor Cell 28CTC 29 Technology with Massachusetts General Hospital 13560 1Veridex LLC Announces Collaboration to Develop Next Generation Circulating Tumor Cell 28CTC 29 Technology with Massachusetts General Hospital 13560 2Veridex LLC Announces Collaboration to Develop Next Generation Circulating Tumor Cell 28CTC 29 Technology with Massachusetts General Hospital 13560 3Veridex LLC Announces Collaboration to Develop Next Generation Circulating Tumor Cell 28CTC 29 Technology with Massachusetts General Hospital 13560 4
... Years Post Surgery, VIENNA, Va., May 21, 2007 ... drug Multikine(R) was,shown to significantly increase long term ... and neck cancer patients. The data were,presented on ... of,the International Association of Oral Oncology in Amsterdam, ...
... Disease Week -, CAMBRIDGE, Mass., May 21, 2007 ... from a Phase 2 study in which,linaclotide accelerated ... constipation- predominant irritable bowel syndrome,(IBS-C). These data also ... of adverse events. Linaclotide is a first-in-class,compound currently ...
Other Medicine Technology:CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 2CEL-SCI Presents Long-Term Cancer Survival Data With Multikine 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 2Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 3Microbia Announces Positive Phase 2 Results for Its Investigational,Compound Linaclotide 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: